Etihad Airways is partnering with Austrian-based healthcare technology company Medicus AI to launch a COVID-19 risk-assessment tool that will empower guests to make informed decisions about travelling.
Powered by Medicus AI’s technology, the risk-assessment tool will guide Etihad’s guests in evaluating the probability of having contracted the COVID-19 coronavirus by responding to a set of 22 questions. The self-administered assessment, which takes less than five minutes to complete, is based on World Health Organisation (WHO) guidelines that are updated daily.
With this risk-assessment tool, guests will understand their individual probability of having contracted the virus alongside advisories and recommendations, allowing them to make informed decisions about travelling.
Frank Meyer, chief digital officer at Etihad Airways, said: “We know that health and wellbeing will be a major factor impacting the travel decisions of our guests and are committed to ensuring their continued safety and peace of mind when they choose to travel with Etihad Airways. As flying operations begin to resume globally, we want to empower our guests to make informed decisions on travel. Partnering with Medicus AI on this innovative new tool is just one of the ways we are adapting our operations and guest experience to meet the new demands placed on the travel industry as a result of COVID-19.”
The tool is now available on Etihad.com and soon on the Etihad Airways mobile application on the Apple iOS, Android and Huawei platforms, and will be accessible in English, with additional language editions such as Arabic, French, German and Portuguese being added in phases.
Etihad Airways has been actively sourcing and investing in innovative solutions to enhance the safety and wellbeing of its employees and guests in light of the impact of COVID-19 and has also recently announced trials of COVID-19 triage and contactless technology at Abu Dhabi International Airport.